Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2008
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470799 Dihydrobenzofuran derivatives and uses thereof
12/30/2008US7470794 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008CA2412452C Process for the preparation of substituted octanoyl amides
12/30/2008CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds
12/29/2008CA2636734A1 Metal coordinated compositions
12/25/2008US20080319209 Process for Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans
12/25/2008US20080319175 Transthyretin Stabilization
12/25/2008US20080319058 Skin Care Products, As Well As Foods And Beverages Containing 6-O-Pufa Ascorbic Esters
12/25/2008US20080319057 2-[[2-[4-(3-Fluoro-benzyloxy)-3-methoxy-phenyl]-ethyl]-isobutylamino]-N-methyl-acetamide, useful in preventing neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urogenital and gastrointestinal disorders
12/25/2008US20080319049 Compounds For the Treatment of Metabolic Disorders
12/25/2008US20080318898 Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof
12/25/2008US20080317671 Non-imidazole heterocyclic compounds
12/25/2008US20080315754 Anthracene derivative and organic electroluminescence device using the same
12/24/2008WO2008157617A1 Method for purifying hydroxymethyl-furfural using non-functional polymeric resins
12/24/2008WO2008157271A1 Deuterium-enriched escitalopram
12/24/2008WO2008156816A2 Renin inhibitors
12/24/2008WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008WO2008156160A1 Composition for transdermal or transmucosal administration
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008155615A2 An improved process for the preparation of cephalosporin antibiotic
12/24/2008WO2008155017A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
12/24/2008WO2008113730A3 Polynary vanadyl pyrophosphate
12/24/2008WO2008113728A3 Polynary metal oxide phosphate
12/24/2008EP2004620A2 Method for the synthesis of 5-alkoxymethyl furfural ethers and their use
12/24/2008EP2004619A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
12/24/2008EP2004590A1 Method of producing a carboxylic alkyl ester
12/24/2008EP2004166A2 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
12/24/2008EP1603555B1 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/24/2008EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
12/24/2008CN101331626A Organic electroluminescence element material and organic electroluminescence element using same
12/24/2008CN100445277C Cesong alkyl type diterpine, its preparation method and use
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
12/24/2008CN100445258C Method for preparing 1,2,4,5-benzene tetra-acid and 1,2,4,5-benzene tetra-anhydride
12/24/2008CN100444839C Treatment of chemokine mediated diseases
12/24/2008CA2690945A1 Composition for transdermal or transmucosal administration
12/24/2008CA2690545A1 Substituted bicyclic heteroaryl compounds and their use
12/24/2008CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/23/2008US7468449 Phenyl-furan compounds as vitamin D receptor modulators
12/23/2008US7468448 Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof
12/23/2008US7468447 Darzen's condensation of 1-(2,2,6-Trimethyl-cyclohexyl)-pentan-3-one, saponifying, pyrolysis, reacting with cyanoacetic acid, ring closing reaction, saponification, cyclization, reduction, ring closure to produce 3a-ethyl-6,6,9a-trimethyldodecahydronaphtho[2,1-b]furan
12/23/2008US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety
12/23/2008US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
12/23/2008US7468360 Therapeutic amides and related compounds
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008154091A1 Thiourea derivatives
12/18/2008WO2008153159A1 Amine compound and pharmaceutical use thereof
12/18/2008WO2008152217A2 Process for preparing 2-(n-butyl)-5-nitrobenzofuran
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008127663A8 Method for reducing impurity level in mycophenolic acid fermentation
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008US20080312450 Method for Start-Up of Oxidation Catalysts
12/18/2008US20080312324 Treatment of lung cells with histone deacetylase inhibitors
12/18/2008US20080312319 Modulation of Bacterial Quorum Sensing with Synthetic Ligands
12/18/2008US20080312318 Deuterium-enriched escitalopram
12/18/2008US20080312293 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080311113 Method for treating adamts-5-associated disease
12/18/2008DE102007028333A1 Verfahren zum Einbringen einer wenigstens einer Produktionscharge von ringförmigen Schalenkatalysatoren K entnommenen Teilmenge in ein Reaktionsrohr eines Rohrbündelreaktors A method for introducing a least one production charge of annular coated catalysts K portion withdrawn in a reaction tube of a tube bundle reactor
12/18/2008DE102007027800A1 Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung Substituted bicyclic heteroaryl compounds and their use
12/18/2008CA2690686A1 Amine compound and pharmaceutical use thereof
12/17/2008EP2003125A1 New tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins
12/17/2008EP2001873A1 Active ingredient combinations with insecticidal properties
12/17/2008EP2001859A1 Method for the synthesis of organic acid esters of 5-hydroxymethylfurfural and their use
12/17/2008EP1673360B1 Furan derivatives as ep4 receptor antagonists
12/17/2008CN101323605A Preparation of isobenzofuran ketone compounds
12/17/2008CN101323604A Novel PPAR alpha/beta dual agonist, preparation and use thereof
12/17/2008CN101323561A Extraction fractional distillation for separating pyrocatechol in furanol
12/17/2008CN100443493C Process of preparing burdock glucoside and glucosidgen thereof
12/17/2008CN100443480C Tricyclic compound and its preparation and use
12/16/2008US7465838 Lithiating a 1-hydroxy-1-arylalkane, carbonylating with dialkylformamide, and reactng with Grignard reagent; diols may be further reacted with phosphorus compounds to form fused ring dioxaphosphepines; their transition metal complexes and their oxides; fused ring phospholanes; and diphosphinites
12/16/2008US7465825 Phenyl substituted carboxylic acids
12/16/2008US7465816 Production of tetrahydrofuran from 1,4-butanediol
12/16/2008US7465815 Cannabinoid receptor modulator
12/11/2008WO2008151170A2 Process for the synthesis of ramelteon and its intermediates
12/11/2008WO2008150953A1 Process of making ramelteon and related substances
12/11/2008WO2008149802A1 Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
12/11/2008WO2008149612A1 Asymmetric bf3 complex
12/11/2008WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor
12/11/2008WO2008148790A1 Anti -inflammatory substituted cyclobutenedione compounds
12/11/2008WO2008148747A2 Pdz domain modulators
12/11/2008WO2008148376A2 Method for producing phthalic anhydride from reaction gases
12/11/2008WO2008148236A1 2,5-di- and 2,2,5-trisubstituted di- and tetrahydrofuran derivatives and their use for the production of perfumes
12/11/2008US20080306278 Process
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306145 Preparation Of Ginkgolide And F-Seco-Ginkgolide Lactols
12/11/2008US20080306117 Ep4 receptor antagonists
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
12/11/2008US20080305164 Crystalline composition containing escitalopram
12/11/2008US20080305138 Photostable Wound Dressing Materials and Methods of Production Thereof
12/11/2008DE102007026360A1 Verfahren zur Gewinnung von Phthalsäureanhydrid aus Reaktionsgasen A process for recovering phthalic anhydride from reaction gases
12/11/2008CA2689581A1 Anti -inflammatory substituted cyclobutenedione compounds
12/10/2008EP2001064A1 Organic electroluminescence element material and organic electroluminescence element using such material
12/10/2008EP2000455A2 Process for production of substituted cyclopentanone
12/10/2008EP1999134A2 Process for the production of anhydrosugar alcohols